Variceal rebleeding frequently develops in patients with cirrhosis after an initial episode of acute variceal hemorrhage. The best prophylactic treatment for variceal rebleeding has not been clearly ...

Gastroesophageal variceal bleeding was common in patients with portal vein thrombosis without cirrhosis. The progression of varices at high risk for bleeding were similar to the development of varices ...

Treatments (NSBB, isosorbide mononitrate, carvedilol, variceal band ligation) were compared as monotherapy or as combination therapy with each other or versus placebo. For cirrhotic patients with ...

A controlled trial conducted by researchers in Taiwan suggests that a combination of band ligation and nadolol may not be the most effective prophylaxis for first variceal bleeding resulting from ...

Therapy for any disease process ideally is judged by the results of a properly designed clinical trial that includes randomization with concealed allocation, double-blinding, a complete accounting of ...

Beta blockers should be the first line of prevention against variceal bleeding in patients with cirrhosis and portal hypertension. While banding is similarly effective in reducing the incidence of ...

Approximately half of patients with advanced liver disease have varicose veins in the esophagus and stomach, and a more than a fifth of them experience bleeding from these varices into the digestive ...

Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the ...

From December 2008 to January 2010, patients with liver cirrhosis and acute gastrointestinal bleeding with hematemesis and/or malena within 24 h of presentation were included. The exclusion criteria ...

Acquired SEPS are associated with portal hypertension, cirrhosis, and complications of decompensation. In particular, the effects of NVEPS on portal pressure are variable, but there is evidence of ...